Table 1.
Gene | Race | Study design | Case | Control | Genotype Distribution1 |
Comparisons | Adjustment2 | Odds ration (95%CI) |
Ref. |
---|---|---|---|---|---|---|---|---|---|
ADPRT V762A | Caucasian | Hospital | 438 | 427 | 70,26,4 73,25,2 |
VA vs. VV AA vs. VV |
Age, BPH, FH |
1.2 (0.9–1.6) 2.7 (1.1–6..5) |
[28] |
African Americans |
Hospital | 50 | 97 | 90,10,0 91,9,0 |
VA vs. VV AA vs. VV |
1.0 (0.2–4.0) NA |
|||
APE1 D148E | Caucasian | Hospital | 228 | 219 | 28,54,18 34,50,16 |
DE vs. DD EE vs. DD |
Age, S, FH | 1.2 (0.8–1.9) 1.2 (0.7–2.2) |
[11] |
African Americans |
Population | 124 | 116 | 34,52,14 38,53,10 |
DE vs. DD EE vs. DD |
Age, S | 1.2 (0.7–2.2) 1.6 (0.6–3.8) |
||
APE1 Q51H | Caucasian | Hospital | 228 | 219 | 89,10, 1 85,14, 1 |
QH vs. QQ HH vs. QQ |
Age, S, FH | 0.6 (0.3–1.2) 0.6 (0.03–14) |
[11] |
African Americans |
Population | 124 | 116 | 79,19, 2 71,26, 3 |
QH vs. QQ HH vs. QQ |
Age, S | 0.8 (0.4–1.5) 0.7 (0.1–3.1) |
||
ATM D1853N | Caucasians | Population | 637 | 455 | 73,24,3 69,28,3 |
ga vs. gg aa vs. gg |
None | 0.8 (0.7–1.1) 1.0 (0.5–2.1) |
[30] |
ATM D1853V | Caucasians | Population | 637 | 455 | 99,1,0 99,1,0 |
ta vs. aa | None | 0.9 (0.2–3.3) | [30] |
ATM ivs38-8t>c | Caucasians | Population | 637 | 455 | 93,7,0 93,7,0 |
ct/cc vs. tt | None | 1.0 (0.6–1.6) | [30] |
ATM ivs38-15g>c | Caucasians | Population | 637 | 455 | 98,2,0 99,1,0 |
gc vs. gg | None | 1.8 (0.6–5.7) | [30] |
ATMP1054R | Caucasians | Population | 637 | 455 | 92,7,0 96,4,0 |
PR/RR vs. PP | None | 2.1 (1.2–3.9) | [30] |
hOGG1 a10660t | Mixed (93% Caucasians) |
Hospital | 245 | 222 | 65,32, 4 61,32, 7 |
tt vs. aa | Age | NS | [16]. |
hOGG1 a11657g | Mixed (93% Caucasians) |
Hospital | 245 | 222 | 70,25, 5 74,25, 1 |
gg vs. aa | Age | 9.8 (1.2–76.9) | [16]. |
Mixed (84% Caucasians) |
Family | 159 | 222 | 67,29, 5 74,25, 1 |
gg vs. aa | Age | 13.9 (1.6–125) | ||
hOGG1 a11657g | Mixed (84% Caucasians) |
Hospital | 996 | 1092 | 70,27, 3 71,25, 4 |
ag vs. aa gg vs. aa |
Age | NS | [26] |
hOGG1 a11826t | Mixed (93% Caucasians) |
Hospital | 245 | 222 | 66,31, 3 60,33, 7 |
tt vs. aa | Age | NS | [16]. |
hOGG1 a7143g | Mixed (93% Caucasians) |
Hospital | 245 | 222 | 68,26, 5 71,28, 1 |
gg vs. aa | Age | 5.1 (1.1–23.3) | [16]. |
Mixed (84% Caucasians) |
Family | 159 | 222 | 64,32, 5 71,28, 1 |
gg vs. aa | Age | 8.2 (1.5–45.5) | ||
hOGG1 a9110g | Mixed (93% Caucasians) |
Hospital | 245 | 222 | 66,31, 3 60,34, 7 |
gg vs. aa | Age | NS | [16]. |
hOGG1 c10629g | Mixed (93% Caucasians) |
Hospital | 245 | 222 | 28,44,27 30,41,30 |
gg vs. cc | Age | NS | [16]. |
hOGG1 g3402a | Mixed (93% Caucasians) |
Hospital | 245 | 222 | 40,44,16 43,45,12 |
aa vs. gg | Age | NS | [16]. |
hOGG1 g3574a | Mixed (93% Caucasians) |
Hospital | 245 | 222 | 67,28, 5 60,34, 6 |
aa vs. gg | Age | NS | [16]. |
hOGG1 g6170c | Mixed (93% Caucasians) |
Hospital | 245 | 222 | 63,33, 4 58,34, 7 |
cc vs. gg | Age | NS | [16]. |
hOGG1 S326C | Caucasians | Hospital | 84 | 252 | 58,35, 7 74,25, 1 |
SC vs. SS CC vs. SS |
Age, S | 1.8 (1.0–3.3) 7.8 (1.7–36) |
[14] |
hOGG1 S326C | Mixed (93% Caucasians) |
Hospital | 245 | 222 | 61,36, 3 55,36, 9 |
CC vs. SS | Age | 0.3 (0.1–0.8) | [16]. |
Mixed (84% Caucasians) |
Family | 159 | 222 | 61,35, 4 55,36, 9 |
CC vs. SS | Age | 0.5 (0.2–1.7) | ||
hOGG1 S326C | Mixed (84% Caucasians) |
Hospital | 996 | 1092 | 60,35, 5 57,35, 8 |
SC vs. SS CC vs. SS |
Age, race, FH, DRE, PSA |
0.9 (0.8–1.1) 0.7 (0.5–1.0) |
[26] |
hOGG1 S326C | Mixed (90% Caucasians) |
Family | 439 | 479 | 64,31, 5 54,30, 6 |
SC vs. SS CC vs. SS |
Age | 1.1 (0.7–1.6) 0.7 (0.3–1.7) |
[18] |
MGMT I143V | Chinese | Population | 162 | 251 | 96, 3, 1 98, 2, 0 |
VV/IV vs. II | Age | 1.9 (0.6–6.2) | [12] |
MGMT L84F | Chinese | Population | 162 | 251 | 76,22,1 86,13,1 |
LF vs. LL FF va. LL |
Age | 2.0 (1.2–3.3) 3.4 (0.3–38.1) |
[12] |
hHR23B A249V | Mixed (90% Caucasians) |
Hospital | 494 | 470 | 293 | AA vs. AV/VV | Age,BPH, FH, S |
1.1 (0.8–1.4) | [17] |
NBS1E185Q | unknown | Family | 121 | 200 | 33,52,15 44,40,16 |
EQ vs. EE QQ vs. EE |
none | 1.4 (0.7–2.8) 0.8 (0.4–1.6) |
[29] |
Population | 200 | 200 | 41,47,12 44,40,16 |
EQ vs. EE QQ vs. EE |
1.6 (0.9–2.9) 1.2 (0.7–2.3) |
||||
XPC A499V | Mixed (90% Caucasians) |
Hospital | 494 | 470 | 243 | AA/AV vs. VV | Age,BPH, FH, S |
0.9(0.5–1.5) | [17] |
XPC K939Q | Mixed (90% Caucasians) |
Hospital | 494 | 470 | 383 | KK/KQ vs. QQ | Age,BPH, FH, S |
1.0 (0.7–1.4) | [17] |
XPC K939Q | Japanese | Hospital | 165 | 165 | 47,47,6 44.42.14 |
KK/KQ vs. QQ | Age | 2.5 (1.1–5.5) | [10] |
XPD c-114g | Taiwanese | Hospital | 123 | 479 | 28,53,19 31,46,23 |
DN/NN vs. DD | 1.0 (0.7–1.5) | [20] | |
XPD D312N | Mixed | Siblings | 637 | 480 | 44,45,12 44,48, 8 |
NN vs. DN/DD | None | 1.6 (1.0–2.5) | [13] |
Caucasian | Siblings | 572 | 437 | 40,47,13 41,50, 9 |
NN vs. DN/DD | None | 1.6 (1.0–2.5) | ||
XPD D312N | Mixed (90% Caucasians) |
Hospital | 494 | 470 | 413 | NN vs. DN/DD | Age,BPH, FH, S |
0.8 (0.5–1.2) | [17] |
XPD D312N | Taiwanese | Hospital | 123 | 479 | 50,32,18 65,22,13 |
DN/NN vs. DD | 1.8 (1.2–2.7) | [20] | |
XPD K751Q | Mixed (90% Caucasians) |
Hospital | 494 | 470 | 353 | KQ/QQ vs. KK | Age,BPH, FH, S |
0.9 (0.6–1.4) | [17] |
XPD K751Q | Chinese | Population | 162 | 251 | 88,12,0 86,13,1 |
KQ/QQ vs. KK | Age | 0.8 (0.5–1.5) | [12] |
XPD K751Q | Mixed | Siblings | 637 | 480 | 40,47,13 41,47,12 |
QQ vs. KQ/KK | None | 1.1 ( 0.7–1.8) | [13] |
Caucasian | Siblings | 572 | 437 | 39,48,13 41,47,12 |
QQ vs. KQ/KK | None | 1.2 (0.7–2.0) | ||
XPD K751Q | Taiwanese | Hospital | 123 | 479 | 91,7,2 92,7,1 |
DN/NN vs. DD | 1.3 (0.6–2.5) | [20] | |
XPF/ERCC4 R415Q | Mixed (90% Caucasians) |
Hospital | 494 | 470 | 93 | RQ vs. RR | Age, BPH, S. FH |
1.4 (1.0–2.0) | [17] |
XPG/ERCC5 D1104H | Mixed (90% Caucasians) |
Hospital | 494 | 470 | 463 | DD/DH vs. HH | Age, BPH, S, FH | 0.8 (0.5–1.5) | [17] |
XRCC1 R194W | Mixed (90% Caucasians) |
Population | 76 | 182 | 88,12,0 84,15,1 |
RW/WW vs. RR |
Age, race | 0.7 (0.3–1.6) | [15] |
XRCC1 R194W | Japanese | Hospital | 165 | 165 | 42,48,13 52,38,10 |
RW/WW vs. RR |
Age | 1.5 (0.9–2.2) | [10] |
XRCC1 R194W | Chinese | Hospital | 207 | 235 | 50,41,9 39,50,11 |
RW/WW vs. RR |
Age,S,AL FH |
0.6 (1.1–2.5) | [31] |
XRCC1 R280H | Mixed (90% Caucasians) |
Population | 76 | 182 | 87,13,0 90,10,0 |
RH vs. RR | Age, race | 1.5 (0.7–3.6) | [15] |
XRCC1 R280H | Chinese | Hospital | 207 | 235 | 80,19,1 82,17,1 |
RR/RH vs. HH |
Age,S,AL FH |
1.1 (0.7–1.9) | [31] |
XRCC1 R399Q | Caucasian | Hospital | 228 | 219 | 42,46,12 50,40,10 |
RQ vs. RR QQ vs. RR |
Age, S, FH | 1.6 (1.1–2.5) 1.6 (0.8–3.1) |
[11] |
African Americans |
Population | 124 | 116 | 73,24,3 73,24,3 |
RQ vs. RR QQ vs. RR |
Age, S | 1.2 (0.6–2.2) 1.5 (0.3–8.2) |
||
XRCC1 R399Q | Chinese | Hospital | 207 | 235 | 52,41,7 65,31,4 |
RR/RQ vs. |
Age,S,AL FH |
1.7 (1.1–2.5) | [31] |
XRCC1 R399Q | Chinese | Population | 162 | 251 | 55,34,11 54,41,5 |
RQ vs. RR QQ vs. RR |
Age | 0.8 (0.5–1.3) 2.2 (1.0–4.8) |
[12] |
XRCC1 R399Q | Japanese | Hospital | 165 | 165 | 53,38,9 52,42,6 |
RQ/QQ vs. RR | Age | 1.0 (0.6–1.5) | [10] |
XRCC1 R399Q | Mixed | Siblings | 637 | 480 | 46,43,11 45,43,12 |
QQ vs. RQ/RR | None | 0.9(0.6–1.4) | [13] |
Caucasians | Siblings | 572 | 437 | 43,45,12 41,46,13 |
QQ vs. RQ/RR | None | 0.9(0.5–1.4) | ||
XRCC1 R399Q | Mixed (90% Caucasians) |
Population | 76 | 182 | 49,39,12 42,43,15 |
RQ vs. RR QQ vs. RR |
Age, race | 0.8 (0.5–1.4) 0.7 (0.3–1.6) |
[15] |
XRCC1 R399Q | Mixed (92% Caucasians) |
Population | 77 | 174 | 49, (51)4 43, (57) |
RQ vs. RR QQ vs. RR |
none | 0.8 (0.4–1.5) 0.7 (0.3–1.7) |
[27] |
XRCC3 T241M | Chinese | Population | 162 | 251 | 87,11,2 87,13,1 |
TM vs. TT MM vs. TT |
Age | 0.8 (0.5–1.6) 2.2 (0.4–13.7) |
[12] |
XRCC7 g6721t | Japanese | Hospital | 165 | 165 | 7,48,45 7,41,52 |
gt/tt vs. gg | Age | 1.0 (0.5–1.2) | [10] |
numbers are percentages of each genotypes, and single number indicates percentage of minor allele frequency
BPH benign prostate hyperplasia, FH: family history of prostate cancer, S, Smoking, AL, alcohol
minor allelic frequency
heteozygous and homozygous polymorphic genotypes were combined